Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,401
archived clinical trials in
Alzheimer Disease

Evaluation of [123I] AV51 and SPECT as a Marker of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects
Status: Enrolling
Updated:  12/31/1969
Molecular Neuroimaging, LLC
mi
from
New Haven, CT
Evaluation of [123I] AV51 and SPECT as a Marker of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Molecular Neuroimaging, LLC
mi
from
New Haven, CT
Click here to add this to my saved trials
Evaluation of [123I]CLINDE and SPECT as a Marker of Inflammation in Subjects With PD or AD and in Healthy Subjects
Evaluation of [123I]CLINDE and SPECT as a Marker of Inflammation in Subjects With Parkinson Disease or Alzheimer Disease and in Healthy Subjects
Status: Enrolling
Updated:  12/31/1969
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
Evaluation of [123I]CLINDE and SPECT as a Marker of Inflammation in Subjects With PD or AD and in Healthy Subjects
Evaluation of [123I]CLINDE and SPECT as a Marker of Inflammation in Subjects With Parkinson Disease or Alzheimer Disease and in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
Click here to add this to my saved trials
Evaluation of [123I] MNI-330 and SPECT as a Marker of Beta-amyloid Protein Deposition
Evaluation of [123I] MNI-330 and Single Photon Emission Computed Tomography (SPECT) as a Marker of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects
Status: Enrolling
Updated:  12/31/1969
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
Evaluation of [123I] MNI-330 and SPECT as a Marker of Beta-amyloid Protein Deposition
Evaluation of [123I] MNI-330 and Single Photon Emission Computed Tomography (SPECT) as a Marker of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
Click here to add this to my saved trials
Brain Imaging Study in Subjects With Alzheimer Disease in Comparison to Healthy Subjects
Evaluation of [123I] MNI-168 and SPECT as a Marker of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects
Status: Enrolling
Updated:  12/31/1969
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
Brain Imaging Study in Subjects With Alzheimer Disease in Comparison to Healthy Subjects
Evaluation of [123I] MNI-168 and SPECT as a Marker of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
Click here to add this to my saved trials
Single Photon Emission Computed Tomography (SPECT) Imaging Study to Develop a Biomarker for Alzheimer's Disease
Evaluation of [123I] MNI-388 and 123-I MNI-390 and SPECT as Markers of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects
Status: Enrolling
Updated:  12/31/1969
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
Single Photon Emission Computed Tomography (SPECT) Imaging Study to Develop a Biomarker for Alzheimer's Disease
Evaluation of [123I] MNI-388 and 123-I MNI-390 and SPECT as Markers of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
Click here to add this to my saved trials
Evaluation of [123I] MNI-340 and SPECT as a Marker of Beta-Amyloid Protein Deposition
Evaluation of [123I] MNI-340 and SPECT as a Marker of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects
Status: Enrolling
Updated:  12/31/1969
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
Evaluation of [123I] MNI-340 and SPECT as a Marker of Beta-Amyloid Protein Deposition
Evaluation of [123I] MNI-340 and SPECT as a Marker of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
Click here to add this to my saved trials
Evaluation of [18F] PBR06 and PET as a Marker of Inflammation in Subjects With Neurological Conditions
Status: Enrolling
Updated:  12/31/1969
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
Evaluation of [18F] PBR06 and PET as a Marker of Inflammation in Subjects With Neurological Conditions
Status: Enrolling
Updated: 12/31/1969
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
Click here to add this to my saved trials
A Comparison of Two Standard Therapies in the Management of Dementia With Agitation
Randomized Comparison of Monotherapy (Risperidone, Quetiapine, or Olanzapine) Versus Combination Therapy (Risperidone, Quetiapine, or Olanzapine + Divalproex)in the Management of Dementia With Agitation: A Pilot Comparison of Two Standard Therapies
Status: Enrolling
Updated:  4/16/2007
Wesley Woods Geriatric Hospital
mi
from
Atlanta, GA
A Comparison of Two Standard Therapies in the Management of Dementia With Agitation
Randomized Comparison of Monotherapy (Risperidone, Quetiapine, or Olanzapine) Versus Combination Therapy (Risperidone, Quetiapine, or Olanzapine + Divalproex)in the Management of Dementia With Agitation: A Pilot Comparison of Two Standard Therapies
Status: Enrolling
Updated: 4/16/2007
Wesley Woods Geriatric Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
GTS21-201 for Alzheimer Disease:GTS-21 Administered Daily for 28 Days to Participants With Probable Alzheimer’s Disease
A Double Blind, Placebo-Controlled Randomized Study to Compare the Safety and Tolerability of GTS-21 (25 Mg TID, 50 Mg TID, 75 Mg TID and 150 Mg TID) When Administered Daily for 28 Days to Participants With Probable Alzheimer’s Disease
Status: Enrolling
Updated:  4/18/2007
Clinical Dept.
mi
from
280 South San Francisco, CA
GTS21-201 for Alzheimer Disease:GTS-21 Administered Daily for 28 Days to Participants With Probable Alzheimer’s Disease
A Double Blind, Placebo-Controlled Randomized Study to Compare the Safety and Tolerability of GTS-21 (25 Mg TID, 50 Mg TID, 75 Mg TID and 150 Mg TID) When Administered Daily for 28 Days to Participants With Probable Alzheimer’s Disease
Status: Enrolling
Updated: 4/18/2007
Clinical Dept.
mi
from
280 South San Francisco, CA
Click here to add this to my saved trials
Couples Coping With Alzheimer's Disease
A Randomized Control Trial of an Intervention for Couples Coping With Alzheimer's Disease
Status: Enrolling
Updated:  9/19/2007
Aging and Dementia Research Center, Silberstein Institute, NYU School of Medicine
mi
from
New York, NY
Couples Coping With Alzheimer's Disease
A Randomized Control Trial of an Intervention for Couples Coping With Alzheimer's Disease
Status: Enrolling
Updated: 9/19/2007
Aging and Dementia Research Center, Silberstein Institute, NYU School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics Study of Bryostatin 1 in Patients With Alzheimer's Disease
A Randomized, Double-Blind, Placebo-Controlled, Parallel Groups, Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Bryostatin 1 in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  1/21/2008
Chestnut Ridge Center West Virginia University Department of Behavioral Medicine and Psychiatry
mi
from
Morgantown, WV
Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics Study of Bryostatin 1 in Patients With Alzheimer's Disease
A Randomized, Double-Blind, Placebo-Controlled, Parallel Groups, Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Bryostatin 1 in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 1/21/2008
Chestnut Ridge Center West Virginia University Department of Behavioral Medicine and Psychiatry
mi
from
Morgantown, WV
Click here to add this to my saved trials
An Innovative Psychosocial Intervention for Adult-Child Caregivers of Parents With Alzheimer's Disease
An Innovative Psychosocial Intervention for Adult-Child Caregivers of Parents With Alzheimer's Disease
Status: Enrolling
Updated:  2/28/2008
Aging and Dementia Research Center, Silberstein Institute, NYU School of Medicine
mi
from
New York, NY
An Innovative Psychosocial Intervention for Adult-Child Caregivers of Parents With Alzheimer's Disease
An Innovative Psychosocial Intervention for Adult-Child Caregivers of Parents With Alzheimer's Disease
Status: Enrolling
Updated: 2/28/2008
Aging and Dementia Research Center, Silberstein Institute, NYU School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Quetiapine for the Treatment of Insomnia in Alzheimer's Disease
Quetiapine for the Treatment of Insomnia Associated With Alzheimer's Disease
Status: Enrolling
Updated:  5/4/2009
Fletcher Allen Health Care-Clinical Neuroscience Research Unit
mi
from
Burlington, VT
Quetiapine for the Treatment of Insomnia in Alzheimer's Disease
Quetiapine for the Treatment of Insomnia Associated With Alzheimer's Disease
Status: Enrolling
Updated: 5/4/2009
Fletcher Allen Health Care-Clinical Neuroscience Research Unit
mi
from
Burlington, VT
Click here to add this to my saved trials
Neural Correlates In Mild Alzheimer's Disease
A Single Center Study To Examine Neural Correlates Of Cognition In Subjects With Mild Alzheimer's Disease After Three Months Of Open Label Donepezil HCl (Aricept® ) Treatment
Status: Enrolling
Updated:  5/6/2009
Pfizer Investigational Site
mi
from
Milwaukee, WI
Neural Correlates In Mild Alzheimer's Disease
A Single Center Study To Examine Neural Correlates Of Cognition In Subjects With Mild Alzheimer's Disease After Three Months Of Open Label Donepezil HCl (Aricept® ) Treatment
Status: Enrolling
Updated: 5/6/2009
Pfizer Investigational Site
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Biomarkers and Early Alzheimer's Disease
Biomarkers and Early Alzheimer's Disease
Status: Enrolling
Updated:  9/16/2009
Center for Brain Health, Silberstein Institute, New York University School of Medicine
mi
from
New York, NY
Biomarkers and Early Alzheimer's Disease
Biomarkers and Early Alzheimer's Disease
Status: Enrolling
Updated: 9/16/2009
Center for Brain Health, Silberstein Institute, New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Predictors of Cognitive Decline in Normal Aging
Predictors of Cognitive Decline in Normal Aging
Status: Enrolling
Updated:  12/10/2009
Center for Brain Health, Silberstein Institute, New York University School of Medicine
mi
from
New York City, NY
Predictors of Cognitive Decline in Normal Aging
Predictors of Cognitive Decline in Normal Aging
Status: Enrolling
Updated: 12/10/2009
Center for Brain Health, Silberstein Institute, New York University School of Medicine
mi
from
New York City, NY
Click here to add this to my saved trials
Enhancing Consent for Alzheimer's Research
Enhancing Consent for Alzheimer's Research
Status: Enrolling
Updated:  12/23/2009
Veterans Affairs San Diego Healthcare System
mi
from
San Diego, CA
Enhancing Consent for Alzheimer's Research
Enhancing Consent for Alzheimer's Research
Status: Enrolling
Updated: 12/23/2009
Veterans Affairs San Diego Healthcare System
mi
from
San Diego, CA
Click here to add this to my saved trials
Implications of Amyloid Pathology
Implications of Amyloid Deposition in Clinically Normal Older Individuals
Status: Enrolling
Updated:  12/23/2009
Brigham and Women's Hosp
mi
from
Boston, MA
Implications of Amyloid Pathology
Implications of Amyloid Deposition in Clinically Normal Older Individuals
Status: Enrolling
Updated: 12/23/2009
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Amyloid Plaque and Tangle Imaging in Alzheimer's Disease and Down Syndrome
Amyloid Plaque and Tangle Imaging in Alzheimer's Disease and Down Syndrome
Status: Enrolling
Updated:  12/23/2009
UCLA
mi
from
Los Angeles, CA
Amyloid Plaque and Tangle Imaging in Alzheimer's Disease and Down Syndrome
Amyloid Plaque and Tangle Imaging in Alzheimer's Disease and Down Syndrome
Status: Enrolling
Updated: 12/23/2009
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Glucose Metabolic, Amyloid, and Tau Brain Imaging in Down Syndrome and Dementia
Glucose Metabolic, Amyloid, and Tau Brain Imaging in Down Syndrome and Dementia
Status: Enrolling
Updated:  12/23/2009
UCLA
mi
from
Los Angeles, CA
Glucose Metabolic, Amyloid, and Tau Brain Imaging in Down Syndrome and Dementia
Glucose Metabolic, Amyloid, and Tau Brain Imaging in Down Syndrome and Dementia
Status: Enrolling
Updated: 12/23/2009
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Genes, Exercise, Memory and Neurodegeneration
Effects of Standardized Aerobic Exercise-Training on Neurocognitive and Neurodegeneration
Status: Enrolling
Updated:  1/24/2010
Howard University General Clinical Research Center (GCRC)
mi
from
Washington,
Genes, Exercise, Memory and Neurodegeneration
Effects of Standardized Aerobic Exercise-Training on Neurocognitive and Neurodegeneration
Status: Enrolling
Updated: 1/24/2010
Howard University General Clinical Research Center (GCRC)
mi
from
Washington,
Click here to add this to my saved trials
Genes, Exercise, Memory and Neurodegeneration
Effects of Standardized Aerobic Exercise-Training on Neurocognitive and Neurodegeneration
Status: Enrolling
Updated:  1/24/2010
Temple University Exercise Physiology Laboratory
mi
from
Philadelphia, PA
Genes, Exercise, Memory and Neurodegeneration
Effects of Standardized Aerobic Exercise-Training on Neurocognitive and Neurodegeneration
Status: Enrolling
Updated: 1/24/2010
Temple University Exercise Physiology Laboratory
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Wii-Fit For Improving Activity, Gait And Balance In Alzheimer's Dementia
Wii-Fit For Improving Activity, Gait And Balance In Alzheimer's Dementia
Status: Enrolling
Updated:  6/1/2010
University of Nebrasaka Medical Center
mi
from
Omaha, NE
Wii-Fit For Improving Activity, Gait And Balance In Alzheimer's Dementia
Wii-Fit For Improving Activity, Gait And Balance In Alzheimer's Dementia
Status: Enrolling
Updated: 6/1/2010
University of Nebrasaka Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Evolution of Memory Related Activity
Evolution of Memory-related fMRI Activation Over the Course of MCI and AD
Status: Enrolling
Updated:  7/23/2010
Brigham and Women's Hosp
mi
from
Boston, MA
Evolution of Memory Related Activity
Evolution of Memory-related fMRI Activation Over the Course of MCI and AD
Status: Enrolling
Updated: 7/23/2010
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Evolution of Memory Related Activity
Evolution of Memory-related fMRI Activation Over the Course of MCI and AD
Status: Enrolling
Updated:  7/23/2010
Massachusetts General Hospital
mi
from
Boston, MA
Evolution of Memory Related Activity
Evolution of Memory-related fMRI Activation Over the Course of MCI and AD
Status: Enrolling
Updated: 7/23/2010
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Effect of Testosterone Therapy in Men With Alzheimer's Disease and Low Testosterone
A Pilot Study of the Effect of Testosterone on Cerebral Glucose Metabolism in Hypogonadal Males With Alzheimer's Disease
Status: Enrolling
Updated:  8/18/2010
Michael E. Debakey VA Medical Center
mi
from
Houston, TX
Effect of Testosterone Therapy in Men With Alzheimer's Disease and Low Testosterone
A Pilot Study of the Effect of Testosterone on Cerebral Glucose Metabolism in Hypogonadal Males With Alzheimer's Disease
Status: Enrolling
Updated: 8/18/2010
Michael E. Debakey VA Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Cerebral and Peripheral Perfusion Pilot Study
Impact of Atorvastatin on Cerebral Perfusion and Endothelial Function
Status: Enrolling
Updated:  9/27/2010
University of Wisconsin
mi
from
Madison, WI
Cerebral and Peripheral Perfusion Pilot Study
Impact of Atorvastatin on Cerebral Perfusion and Endothelial Function
Status: Enrolling
Updated: 9/27/2010
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Effects of Strengthening Exercise on the Brain for Early Dementia and Normative Older Adults
Neuropsychological and Neuroimaging Effects of Strengthening Exercise for Early Dementia and Normative Older Adults
Status: Enrolling
Updated:  12/30/2010
Stratton VA Medical Center
mi
from
Albany, NY
Effects of Strengthening Exercise on the Brain for Early Dementia and Normative Older Adults
Neuropsychological and Neuroimaging Effects of Strengthening Exercise for Early Dementia and Normative Older Adults
Status: Enrolling
Updated: 12/30/2010
Stratton VA Medical Center
mi
from
Albany, NY
Click here to add this to my saved trials
PRISM Registry: Pseudobulbar Affect Registry Series
PRISM Registry: Pseudobulbar Affect Registry Series
Status: Enrolling
Updated:  6/2/2011
Avanir Pharmaceuticals
mi
from
Aliso Viejo, CA
PRISM Registry: Pseudobulbar Affect Registry Series
PRISM Registry: Pseudobulbar Affect Registry Series
Status: Enrolling
Updated: 6/2/2011
Avanir Pharmaceuticals
mi
from
Aliso Viejo, CA
Click here to add this to my saved trials
AC-1204 Long-term Efficacy Response Trial (ALERT Protocol)
A Phase 2-3, 6-12 Month, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Subjects With Mild to Moderate Alzheimer's Disease Who Are APOE4(-)
Status: Enrolling
Updated:  6/7/2011
Meridien Research
mi
from
St Petersburg, FL
AC-1204 Long-term Efficacy Response Trial (ALERT Protocol)
A Phase 2-3, 6-12 Month, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Subjects With Mild to Moderate Alzheimer's Disease Who Are APOE4(-)
Status: Enrolling
Updated: 6/7/2011
Meridien Research
mi
from
St Petersburg, FL
Click here to add this to my saved trials
Study of the Pharmacokinetics and Pharmacodynamics of POSIPHEN® in Subjects With Amnestic Mild Cognitive Impairment
An Open-Label, Two-Stage Study to Evaluate the Pharmacokinetics and Pharmacodynamics of POSIPHEN® in Plasma and CSF After a 10-Day Treatment Period in Subjects With Amnestic Mild Cognitive Impairment
Status: Enrolling
Updated:  6/11/2011
CEDRA Clinical Research, LLC
mi
from
San Antonio, TX
Study of the Pharmacokinetics and Pharmacodynamics of POSIPHEN® in Subjects With Amnestic Mild Cognitive Impairment
An Open-Label, Two-Stage Study to Evaluate the Pharmacokinetics and Pharmacodynamics of POSIPHEN® in Plasma and CSF After a 10-Day Treatment Period in Subjects With Amnestic Mild Cognitive Impairment
Status: Enrolling
Updated: 6/11/2011
CEDRA Clinical Research, LLC
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety and Efficacy Study of Magnetic Fields to Treat Alzheimer's Disease
A Randomized, Single-Blind, Placebo-Controlled Pilot Study to Evaluate the Safety and Efficacy of the Application of Magnetic Fields Using the Resonator for the Treatment of Alzheimer's Disease in Addition to Standard of Care
Status: Enrolling
Updated:  7/7/2011
USF Health Byrd Alzheimer's Institute
mi
from
Tampa, FL
Safety and Efficacy Study of Magnetic Fields to Treat Alzheimer's Disease
A Randomized, Single-Blind, Placebo-Controlled Pilot Study to Evaluate the Safety and Efficacy of the Application of Magnetic Fields Using the Resonator for the Treatment of Alzheimer's Disease in Addition to Standard of Care
Status: Enrolling
Updated: 7/7/2011
USF Health Byrd Alzheimer's Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
Effects of Memantine on Magnetic Resonance (MR) Spectroscopy in Subjects at Risk for Alzheimer's Disease
Effects of Memantine on the Magnetic Resonance Spectroscopy (MRS) Measures of Neuronal Integrity in Subjects at Risk for Alzheimer's Disease
Status: Enrolling
Updated:  7/20/2011
NYU School of Medicine, Dept. of Psychiatry, Center for Brain Health
mi
from
New York, NY
Effects of Memantine on Magnetic Resonance (MR) Spectroscopy in Subjects at Risk for Alzheimer's Disease
Effects of Memantine on the Magnetic Resonance Spectroscopy (MRS) Measures of Neuronal Integrity in Subjects at Risk for Alzheimer's Disease
Status: Enrolling
Updated: 7/20/2011
NYU School of Medicine, Dept. of Psychiatry, Center for Brain Health
mi
from
New York, NY
Click here to add this to my saved trials
Study of the Effect of Repetitive Transcranial Magnetic Stimulation on Language in Patients With Alzheimer's Disease
Open-label, Exploratory Study of the Efficacy of Repetitive Transcranial Magnetic Stimulation on Naming and Verbal Fluency in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  7/21/2011
The NY Memory Services
mi
from
New York, NY
Study of the Effect of Repetitive Transcranial Magnetic Stimulation on Language in Patients With Alzheimer's Disease
Open-label, Exploratory Study of the Efficacy of Repetitive Transcranial Magnetic Stimulation on Naming and Verbal Fluency in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 7/21/2011
The NY Memory Services
mi
from
New York, NY
Click here to add this to my saved trials
History of Amyloid Deposition in Adults With Down Syndrome
Natural History of Amyloid Deposition in Adults With Down Syndrome
Status: Enrolling
Updated:  8/5/2011
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
History of Amyloid Deposition in Adults With Down Syndrome
Natural History of Amyloid Deposition in Adults With Down Syndrome
Status: Enrolling
Updated: 8/5/2011
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Exercise Trial for Alzheimer's Disease
Exercise Trial for Alzheimer's Disease (EXTRA)
Status: Enrolling
Updated:  9/19/2011
Pennington Biomedical Research Center
mi
from
Baton Rouge, LA
Exercise Trial for Alzheimer's Disease
Exercise Trial for Alzheimer's Disease (EXTRA)
Status: Enrolling
Updated: 9/19/2011
Pennington Biomedical Research Center
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Exercise Trial for Alzheimer's Disease
Exercise Trial for Alzheimer's Disease (EXTRA)
Status: Enrolling
Updated:  9/19/2011
Programs of All-Inclusive Care for the Elderly (PACE)
mi
from
Baton Rouge, LA
Exercise Trial for Alzheimer's Disease
Exercise Trial for Alzheimer's Disease (EXTRA)
Status: Enrolling
Updated: 9/19/2011
Programs of All-Inclusive Care for the Elderly (PACE)
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Study of Social Behavior and Emotion in Frontotemporal Dementia, Alzheimer's Disease and Controls
Study of Social Behavior and Emotion in Frontotemporal Dementia, Alzheimer's Disease and Controls
Status: Enrolling
Updated:  10/27/2011
UCLA Department of Neurology
mi
from
Los Angeles, CA
Study of Social Behavior and Emotion in Frontotemporal Dementia, Alzheimer's Disease and Controls
Study of Social Behavior and Emotion in Frontotemporal Dementia, Alzheimer's Disease and Controls
Status: Enrolling
Updated: 10/27/2011
UCLA Department of Neurology
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup—A Pilot Descriptive Study
Status: Archived
Updated:  12/12/2011
Cleveland Clinic Lou Ruvo Center for Brain Health
mi
from
Las Vegas, NV
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup—A Pilot Descriptive Study
Status: Archived
Updated: 12/12/2011
Cleveland Clinic Lou Ruvo Center for Brain Health
mi
from
Las Vegas, NV
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup—A Pilot Descriptive Study
Status: Archived
Updated:  12/12/2011
Cleveland Clinic Center for Brain Health - Mellen Center
mi
from
Cleveland, OH
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup—A Pilot Descriptive Study
Status: Archived
Updated: 12/12/2011
Cleveland Clinic Center for Brain Health - Mellen Center
mi
from
Cleveland, OH
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup—A Pilot Descriptive Study
Status: Archived
Updated:  12/12/2011
Cleveland Clinic Senior Care Assessment - Lakewood Hospital
mi
from
Lakewood, OH
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup—A Pilot Descriptive Study
Status: Archived
Updated: 12/12/2011
Cleveland Clinic Senior Care Assessment - Lakewood Hospital
mi
from
Lakewood, OH
Minocycline in Patients With Alzheimer's Disease
MRI and MRS Diagnosis and Treatment Monitoring of Alzheimer's Disease With Novel Therapy
Status: Enrolling
Updated:  1/30/2012
Huntington Medical Research Institutes
mi
from
Pasadena, CA
Minocycline in Patients With Alzheimer's Disease
MRI and MRS Diagnosis and Treatment Monitoring of Alzheimer's Disease With Novel Therapy
Status: Enrolling
Updated: 1/30/2012
Huntington Medical Research Institutes
mi
from
Pasadena, CA
Click here to add this to my saved trials
Conversations as a Means to Delay the Onset of Alzheimer's Disease
Conversational Engagement as a Means to Delay Alzheimer's Disease Onset
Status: Enrolling
Updated:  4/4/2012
Oregon Health and Science University
mi
from
Portland, OR
Conversations as a Means to Delay the Onset of Alzheimer's Disease
Conversational Engagement as a Means to Delay Alzheimer's Disease Onset
Status: Enrolling
Updated: 4/4/2012
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Citalopram for Agitation in Alzheimer's Disease
A Multi-Center Randomized Placebo-Controlled Clinical Trial Study of Citalopram for the Treatment of Agitation in Alzheimer's Disease
Status: Enrolling
Updated:  5/3/2012
University of Southern California Keck School of Medicine Memory and Aging Center
mi
from
Los Angeles, CA
Citalopram for Agitation in Alzheimer's Disease
A Multi-Center Randomized Placebo-Controlled Clinical Trial Study of Citalopram for the Treatment of Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 5/3/2012
University of Southern California Keck School of Medicine Memory and Aging Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Citalopram for Agitation in Alzheimer's Disease
A Multi-Center Randomized Placebo-Controlled Clinical Trial Study of Citalopram for the Treatment of Agitation in Alzheimer's Disease
Status: Enrolling
Updated:  5/3/2012
VA Palo Alto Health Care System
mi
from
Palo Alto, CA
Citalopram for Agitation in Alzheimer's Disease
A Multi-Center Randomized Placebo-Controlled Clinical Trial Study of Citalopram for the Treatment of Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 5/3/2012
VA Palo Alto Health Care System
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Citalopram for Agitation in Alzheimer's Disease
A Multi-Center Randomized Placebo-Controlled Clinical Trial Study of Citalopram for the Treatment of Agitation in Alzheimer's Disease
Status: Enrolling
Updated:  5/3/2012
Johns Hopkins University
mi
from
Baltimore, MD
Citalopram for Agitation in Alzheimer's Disease
A Multi-Center Randomized Placebo-Controlled Clinical Trial Study of Citalopram for the Treatment of Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 5/3/2012
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Citalopram for Agitation in Alzheimer's Disease
A Multi-Center Randomized Placebo-Controlled Clinical Trial Study of Citalopram for the Treatment of Agitation in Alzheimer's Disease
Status: Enrolling
Updated:  5/3/2012
Columbia University
mi
from
New York, NY
Citalopram for Agitation in Alzheimer's Disease
A Multi-Center Randomized Placebo-Controlled Clinical Trial Study of Citalopram for the Treatment of Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 5/3/2012
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Citalopram for Agitation in Alzheimer's Disease
A Multi-Center Randomized Placebo-Controlled Clinical Trial Study of Citalopram for the Treatment of Agitation in Alzheimer's Disease
Status: Enrolling
Updated:  5/3/2012
Monroe Community Hospital
mi
from
Rochester, NY
Citalopram for Agitation in Alzheimer's Disease
A Multi-Center Randomized Placebo-Controlled Clinical Trial Study of Citalopram for the Treatment of Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 5/3/2012
Monroe Community Hospital
mi
from
Rochester, NY
Click here to add this to my saved trials
Citalopram for Agitation in Alzheimer's Disease
A Multi-Center Randomized Placebo-Controlled Clinical Trial Study of Citalopram for the Treatment of Agitation in Alzheimer's Disease
Status: Enrolling
Updated:  5/3/2012
University of Pennsylvania, Section of Geriatric Psychiatry, Ralston House
mi
from
Philadelphia, PA
Citalopram for Agitation in Alzheimer's Disease
A Multi-Center Randomized Placebo-Controlled Clinical Trial Study of Citalopram for the Treatment of Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 5/3/2012
University of Pennsylvania, Section of Geriatric Psychiatry, Ralston House
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Citalopram for Agitation in Alzheimer's Disease
A Multi-Center Randomized Placebo-Controlled Clinical Trial Study of Citalopram for the Treatment of Agitation in Alzheimer's Disease
Status: Enrolling
Updated:  5/3/2012
Medical University of South Carolina Alzheimer's Research and Clinical Programs
mi
from
Charleston, SC
Citalopram for Agitation in Alzheimer's Disease
A Multi-Center Randomized Placebo-Controlled Clinical Trial Study of Citalopram for the Treatment of Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 5/3/2012
Medical University of South Carolina Alzheimer's Research and Clinical Programs
mi
from
Charleston, SC
Click here to add this to my saved trials